SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (9083)12/30/2001 5:34:26 PM
From: quidditch  Read Replies (2) | Respond to of 9719
 
Spec, VD, isn't PRCS to be differentiated from IMCL as efficacy not shown--i.e., lead drug cast aside putting longer term crimp in the story, as vs. IMCL, where, if rumors and Yahoo posters to be believed, it's a "give us more information...lead drug still alive story"? Wouldn't that affect your sense of how long/precipitous the decline?

quid


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News